Iron Deficiency Clinical Trial
Official title:
Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants
Verified date | August 2014 |
Source | Uppsala University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
Delayed clamping of the umbilical cord might prevent or slow the onset of iron deficiency by
increasing the infant's iron endowment at birth. Compared with early clamping, a delay of
around 2-3 min provides an additional 25-40 mL of blood per kg of bodyweight.
The results of previous intervention studies on delayed clamping are mixed, and few followed
up infants beyond the perinatal period. All longer follow up studies have been performed in
low income countries. The main objectives, therefore, was to assess whether delayed cord
clamping improves hematological and iron status at 4 respective 12 months of age in a large
sample of full-term, Swedish infants.
The investigators also choose to investigate if the timing of clamping the umbilical cord
could affect rate of infections during the first four months of life and to assess the
infants development at 4 and 12 months of age.
Status | Completed |
Enrollment | 392 |
Est. completion date | May 2010 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 37 Weeks to 42 Weeks |
Eligibility |
Inclusion Criteria: - non-smoking mother - healthy mother (no hemolytic disease, no treatment with any of the following drugs: anticonvulsants, antidepressants, thyroid hormone, insulin, chemotherapy or cortisone), - normal pregnancy (no preeclampsia, no diabetes, no prolonged rupture of membranes or signs of infection) - single birth, term pregnancy (gestational age 37 +0 until 41 +6 weeks + days) - expected vaginal delivery with cephalic presentation - mother should be able to master Swedish well enough to participate in the study - mother should live close enough to the hospital to be ready to return for follow up after four months. Exclusion Criteria: - Serious congenital malformation, syndrome or other congenital disease that can affect the outcome measures |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Sweden | Länsjukhuset i Halmstad | Halmstad | Halland |
Lead Sponsor | Collaborator |
---|---|
Uppsala University | County Council of Halland, Sweden, Halmstad County Hospital, Umeå University |
Sweden,
Andersson O, Domellöf M, Andersson D, Hellström-Westas L. Effect of delayed vs early umbilical cord clamping on iron status and neurodevelopment at age 12 months: a randomized clinical trial. JAMA Pediatr. 2014 Jun;168(6):547-54. doi: 10.1001/jamapediatri — View Citation
Andersson O, Domellöf M, Andersson D, Hellström-Westas L. Effects of delayed cord clamping on neurodevelopment and infection at four months of age: a randomised trial. Acta Paediatr. 2013 May;102(5):525-31. doi: 10.1111/apa.12168. Epub 2013 Feb 11. — View Citation
Andersson O, Hellström-Westas L, Andersson D, Clausen J, Domellöf M. Effects of delayed compared with early umbilical cord clamping on maternal postpartum hemorrhage and cord blood gas sampling: a randomized trial. Acta Obstet Gynecol Scand. 2013 May;92(5 — View Citation
Andersson O, Hellström-Westas L, Andersson D, Domellöf M. Effect of delayed versus early umbilical cord clamping on neonatal outcomes and iron status at 4 months: a randomised controlled trial. BMJ. 2011 Nov 15;343:d7157. doi: 10.1136/bmj.d7157. — View Citation
Begley CM, Gyte GM, Murphy DJ, Devane D, McDonald SJ, McGuire W. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007412. doi: 10.1002/14651858.CD007412.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(11):CD007412. — View Citation
Ceriani Cernadas JM, Carroli G, Pellegrini L, Otaño L, Ferreira M, Ricci C, Casas O, Giordano D, Lardizábal J. The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: a randomized, controlled trial. Pediatrics. 2006 Apr;117(4):e779-86. Epub 2006 Mar 27. — View Citation
Chaparro CM, Fornes R, Neufeld LM, Tena Alavez G, Eguía-Líz Cedillo R, Dewey KG. Early umbilical cord clamping contributes to elevated blood lead levels among infants with higher lead exposure. J Pediatr. 2007 Nov;151(5):506-12. Epub 2007 Sep 17. — View Citation
Grajeda R, Pérez-Escamilla R, Dewey KG. Delayed clamping of the umbilical cord improves hematologic status of Guatemalan infants at 2 mo of age. Am J Clin Nutr. 1997 Feb;65(2):425-31. — View Citation
Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA. 2007 Mar 21;297(11):1241-52. Review. — View Citation
McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004074. doi: 10.1002/14651858.CD004074.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004074. — View Citation
Mercer JS. Current best evidence: a review of the literature on umbilical cord clamping. J Midwifery Womens Health. 2001 Nov-Dec;46(6):402-14. Review. — View Citation
van Rheenen P, de Moor L, Eschbach S, de Grooth H, Brabin B. Delayed cord clamping and haemoglobin levels in infancy: a randomised controlled trial in term babies. Trop Med Int Health. 2007 May;12(5):603-16. — View Citation
van Rheenen PF, Gruschke S, Brabin BJ. Delayed umbilical cord clamping for reducing anaemia in low birthweight infants: implications for developing countries. Ann Trop Paediatr. 2006 Sep;26(3):157-67. Review. — View Citation
* Note: There are 13 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Do time for clamping the umbilical cord affect children's hemoglobin and iron status at 4 months of age? | Using mean cell volume (MCV), mean cell hemoglobin concentration (MCHC), reticulocyte hemoglobin, serum ferritin, transferrin saturation and soluble transferrin receptors to assess iron status | 4 months of age (plus or minus three weeks) | Yes |
Secondary | Do the time for clamping the umbilical cord affect children's hemoglobin and iron status at 12 months of age? | Using mean cell volume (MCV), mean cell hemoglobin concentration (MCHC), reticulocyte hemoglobin, serum ferritin, transferrin saturation and soluble transferrin receptors to assess iron status. | 12 months of age (plus or minus one month) | No |
Secondary | Are the rates of successful umbilical arterial samples equal between the groups? | Arterial blood samples are obtained with different methods between groups: in the early clamped group samples are taken from the placental part of the clamped cord, in the delayed clamped group samples are taken before clamping in the still pulsating cord. At the same time umbilical venous samples are obtained. A arterial blood sample is assessed as successful when ph < 0.2 and partial pressure of carbon dioxide (pCO2) > 0.5 kPa compared to the venous sample. | Immediately after birth (within 30 seconds) | No |
Secondary | Is there a difference in development as assessed by the Ages and Stages Questionnaire at 4 months of age? | Ages and Stages Questionnaire is a parent report questionnaire available for developmental screening of children from one month to 5 ½ years. 30 questions are divided into 5 developmental domains (communication, gross motor, fine motor, problem solving and personal-social). Total score and scores within separate domains from the 4-month questionnaire will be assessed. | 4 months of age (plus or minus three weeks) | No |
Secondary | Do the time for umbilical cord clamping affect incidence of infections during the first four months of life? | After birth of their child, until four months of age parents fill out a form where they daily note if their infant has intestinal or respiratory symptoms, as well as if the infant has middle ear infection, has visited a doctor, has had an antibiotic prescription or has been admitted into a hospital. | 4 months of age (plus or minus three weeks) | No |
Secondary | Is Reticulocyte hemoglobin a useful measure of iron stores at 2-3 days of age? | Reticulocyte hemoglobin (RetHE) is a novel measure suggested to describe iron status. Ret HE will be compared to other indicators of iron stores: mean cell volume (MCV), mean cell hemoglobin concentration (MCHC), serum ferritin, transferrin saturation and soluble transferrin receptors | Mean 2 to 3 days of age (within 48-96 hours after birth) | No |
Secondary | Do the time for umbilical cord clamping affect neonatal outcomes: anemia, polycythemia and need for phototherapy? | Anemia defined as hemoglobin < 145 g/L, polycythemia defined as hematocrit > 0.65. | Within 7 days after birth | Yes |
Secondary | Is there any difference in post partum haemorrhage when using early cord clamping compared to delayed cord clamping with oxytocin administered after clamping? | Measuring time to placental abortion, post partal hemorrhage and mothers post partum need for blood transfusion | After giving birth until discharge from maternity ward | Yes |
Secondary | Is there a difference in development as assessed by the Ages and Stages Questionnaire at 12 months of age? | Ages and Stages Questionnaire is a parent report questionnaire available for developmental screening of children from one month to 5 ½ years. 30 questions are divided into 5 developmental domains (communication, gross motor, fine motor, problem solving and personal-social). Total score and scores within separate domains from the 12-month questionnaire will be assessed. | 12 months of age (plus or minus one month) | No |
Secondary | Do the time for umbilical cord clamping affect Immunoglobulin G levels at 2-3 days of age? | Blood samples for metabolic screening are routinely taken as soon as possible after 2 days (48 hours) of age. At the same time samples for Immunoglobulin G is obtained. | Mean 2 to 3 days of age (within 48-96 hours after birth) | No |
Secondary | Is Reticulocyte hemoglobin a useful measure of iron stores at 12 months of age? | Reticulocyte hemoglobin (RetHE) is a novel measure suggested to describe iron status. Ret HE will be compared to other indicators of iron stores: mean cell volume (MCV), mean cell hemoglobin concentration (MCHC), serum ferritin, transferrin saturation and soluble transferrin receptors | 12 months of age (plus or minus one month) | No |
Secondary | Does the time for umbilical cord clamping affect the infants respiration within the first 6 hours of life? | Midwives observes the newborn infant at 1 hour and 6 hours of age and note presence of tachypnea (> 60 breaths/minute), grunting, nostril flaring and or retractions between or under the ribs. | Within 6 hours after birth | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01483768 -
Study of Sleeve Gastrectomy on Iron Intestinal Absorption in Morbidly Obese Patients
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Recruiting |
NCT02242188 -
Supplementing Iron and Development in Breastfed Infants (SIDBI Study)
|
Phase 4 | |
Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT01991626 -
Evaluation of the Effects of an Exogenous Phytase on Iron Absorption From LNS Added to Complementary Foods
|
N/A | |
Completed |
NCT01687062 -
Iron Absorption From Tef-injera in Women of Reproductive Age
|
N/A | |
Completed |
NCT01573013 -
Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children
|
N/A | |
Completed |
NCT01443832 -
Iron Absorption From Iron-fortified Fonio Porridge: a Stable Isotope Study
|
Phase 0 | |
Completed |
NCT01191463 -
The Efficacy of a Local Vitamin-C Rich Fruit (Guava) in Improving Iron Absorption From Mungbean Based Meals and Its Effect on Iron Status of Rural Indian Children (6-10 Years)
|
N/A | |
Completed |
NCT01061307 -
An Efficacy Trial of Iron, Zinc and Vitamin A Fortified Rice in Children in Satun, Thailand
|
Phase 0 | |
Not yet recruiting |
NCT00515918 -
The Effect of Early Iron Deficiency on Developmental Brain and Behavior in Infants
|
N/A | |
Recruiting |
NCT00378469 -
Study of the Effects of Muscular Activity on Iron Metabolism
|
N/A | |
Recruiting |
NCT05992116 -
Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction
|
||
Completed |
NCT05262634 -
Pregnancy Outcome in Women With an Iron Deficiency in the First Trimester
|
||
Completed |
NCT06080555 -
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
|
Phase 1 | |
Completed |
NCT04602247 -
Evaluation of Iron Bioavailability From Iron Chlorophyllin
|
N/A | |
Completed |
NCT02996786 -
Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners
|
N/A | |
Completed |
NCT02175888 -
The Optimization of Bioavailability From Iron Supplements: Study 1
|
N/A |